Eliem Therapeutics (ELYM)
NASDAQ:ELYM
US Market
Holding ELYM?
Track your performance easily

Eliem Therapeutics (ELYM) Technical Analysis

47 Followers

Technical Sentiment

Overall Consensus
Sell
5Bullish
4Neutral
13Bearish
Technical Analysis Consensus
Buy
4Bullish
4Neutral
2Bearish
Moving Average Consensus
Strong Sell
1Bullish
0Neutral
11Bearish
Eliem Therapeutics’s (ELYM) Moving Averages Convergence Divergence (MACD) indicator is -0.59, suggesting Eliem Therapeutics is a Buy.
Eliem Therapeutics’s (ELYM) 20-Day exponential moving average is 6.21, while Eliem Therapeutics’s (ELYM) share price is $5.11, making it a Sell.
Eliem Therapeutics’s (ELYM) 50-Day exponential moving average is 6.70, while Eliem Therapeutics’s (ELYM) share price is $5.11, making it a Sell.

Eliem Therapeutics (ELYM) Pivot Points

Nov 08, 2024, 03:35 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
3.62
4.22
4.66
5.26
5.70
6.30
6.74
Fibonacci
4.22
4.62
4.86
5.26
5.66
5.90
6.30
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Eliem Therapeutics (ELYM) Moving Averages

Nov 08, 2024, 03:35 AM
Period
Simple
Exponential
MA5
5.12Buy
5.22Sell
MA10
5.53Sell
5.64Sell
MA20
6.81Sell
6.21Sell
MA50
6.83Sell
6.70Sell
MA100
7.29Sell
6.59Sell
MA200
5.41Sell
5.30Sell
Eliem Therapeutics’s (ELYM) 10-Day exponential moving average is 5.64, while Eliem Therapeutics’s (ELYM) share price is $5.11, making it a Sell.
Eliem Therapeutics’s (ELYM) 100-Day exponential moving average is 6.59, while Eliem Therapeutics’s (ELYM) share price is $5.11, making it a Sell.
Eliem Therapeutics’s (ELYM) stock price is $5.11 and Eliem Therapeutics’s (ELYM) 50-day simple moving average is 6.83, creating a Sell signal.
Eliem Therapeutics’s (ELYM) stock price is $5.11 and Eliem Therapeutics’s (ELYM) 100-day simple moving average is 7.29, creating a Sell signal.
Eliem Therapeutics’s (ELYM) stock price is $5.11 and Eliem Therapeutics’s (ELYM) 200-day simple moving average is 5.41, creating a Sell signal.

Eliem Therapeutics (ELYM) Technical Indicators

Nov 08, 2024, 03:35 AM
Name
Value
Implied Action
RSI (14)
32.56
Neutral
STOCH (9,6)
10.15
Buy
STOCHRSI (14)
9.36
Buy
MACD (12,26)
-0.59
Buy
ADX (14)
31.82
Neutral
Williams %R
-89.40
Buy
CCI (14)
-90.84
Neutral
ATR (14)
0.67
-
Ultimate Oscillator
38.75
Neutral
ROC
-37.38
Sell
Eliem Therapeutics’s (ELYM) Relative Strength Index (RSI) is 32.56, creating a Neutral signal.
Eliem Therapeutics’s (ELYM) Trend Strength Indicator (ADX) is 31.82, creating a Neutral signal.
Eliem Therapeutics’s (ELYM) Commodity Channel Index (CCI) is -90.84, creating a Neutral signal.
Eliem Therapeutics’s (ELYM) Price Rate of Change (ROC) is -37.38, creating a Sell signal.

FAQ

Is ELYM a Buy, Hold, or Sell?
Based on ELYM’s technical indicators, ELYM is a Sell.
    What is ELYM’s RSI (14)?
    ELYM’s RSI (14) is 32.56, which suggests ELYM is a Neutral.
      What is ELYM’s MACD?
      ELYM’s MACD is -0.59, which suggests ELYM is a Buy.
        What is ELYM’s 5-day moving average?
        ELYM’s 5-day moving average is 5.12, which suggests ELYM is a Buy.
          What is ELYM’s 20-day moving average?
          ELYM 20-day moving average is 6.81, which suggests ELYM is a Sell.
            What is ELYM’s 50-day moving average?
            ELYM’s 50-day moving average is 6.83, which suggests ELYM is a Sell.
              What is ELYM’s 200-day moving average?
              ELYM’s 200-day moving average is 5.41, which suggests ELYM is a Sell.
                What is ELYM’s Williams % R (14)?
                ELYM’s Williams % R (14) is -89.40, which suggests ELYM is a Buy.
                  What is ELYM’s CCI (14)?
                  ELYM’s CCI (14) is -90.84, which suggests ELYM is a Neutral.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis